STAT3 and non-small cell lung carcinoma: Physalin A modulated the tyrosine phosphorylation of JAK2 and JAK3 in a dose-dependent manner and abrogated the nuclear translocation and transcriptional activity of STAT3, showing anticancer activity in NSCLC [200].